UK markets closed

Marinus Pharmaceuticals, Inc. (MRNS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3700+0.0300 (+2.24%)
As of 03:25PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts11111111
Avg. Estimate-0.59-0.45-1.96-1.04
Low estimate-0.68-0.63-2.58-2.06
High estimate-0.52-0.37-1.44-0.59
Year ago EPS-0.61-0.61-2.63-1.96
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts11111111
Avg. Estimate9.49M10.23M39.34M58.17M
Low estimate7.92M8.67M34.01M37.4M
High estimate13.76M13.66M53.4M89.9M
Year ago sales6.08M7.34M30.99M39.34M
Sales growth (year/est)56.10%39.40%26.90%47.90%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.72-0.66-0.62-0.66
Actual EPS-0.61-0.61-0.74-0.68
Difference0.110.05-0.12-0.02
Surprise %15.30%7.60%-19.40%-3.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.59-0.45-1.96-1.04
7 days ago-0.6-0.54-2.19-1.29
30 days ago-0.58-0.56-2.36-1.87
60 days ago-0.58-0.57-2.37-1.88
90 days ago-0.56-0.53-2.27-1.63
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days3342
Up last 30 days6678
Down last 7 daysN/AN/AN/AN/A
Down last 30 days332N/A
Growth estimatesMRNSIndustrySector(s)S&P 500
Current qtr.3.30%N/AN/AN/A
Next qtr.26.20%N/AN/AN/A
Current year25.50%N/AN/AN/A
Next year46.90%N/AN/AN/A
Next 5 years (per annum)20.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A